Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60: Characterization by comparative genomic hybridization and fluorescence in situ hybridization

Genes Chromosomes and Cancer

Volumn 15, Issue 3, 1996, Pages 182-186

  Shipley, Janet ^a   Weber Hall, Stephen ^a   Birdsall, Sandra ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW CULTURE; CELL STRAIN HL 60; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION 5; FLUORESCENCE IN SITU HYBRIDIZATION; GENOME; HUMAN; HUMAN CELL; HYBRIDIZATION; MYELOID LEUKEMIA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 8; CHROMOSOMES, HUMAN, PAIR 9; GENES, MYC; HL-60 CELLS; HUMANS; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, PROMYELOCYTIC, ACUTE; TRANSLOCATION, GENETIC;

EID: 0029930277     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199603)15:3<182::AID-GCC7>3.0.CO;2-Z     Document Type: Article

References (30)

1. Birnie GD (1988) The HL60 cell line: A model system for studying human myeloid cell differentiation. Br J Cancer 58:41-45.
2. Collins SJ, Groudine M (1982) Amplification of endogenous myc-related DNA sequences in a human myeloid leukemia cell line. Nature 298:679-681.
3. Dalla-Favera R, Wong-Staal F, Gallo RC (1982) One-gene amplification in the promyelocytic leukaemia cell line HL-60 and primary leukaemic cells from the same patient. Nature 299:61-63.
4. Dalton WT, Ahearn MJ, McCredie KB, Freireich EJ, Stass AS, Trujillo JM (1988) HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 71:242-247.
5. Donti E, Lanfrancone L, Pelicci P, Birnie GD, Dalla-Favcra R (1991) Loss of amplification and appearance of a novel translocation site of the c-myc oncogcne in HL-60 leukemia cells. Cancer Genet Cytogenet 56:57-64.
6. du Manoir S, Speicher MR, Joos S, Schrock E, Popp S, Dohner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T (1993) Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590-610.
7. Eckhardt SG, Dai A, Davidson KK, Forseth BJ, Wahl GM, Hoff DDV (1994) Induction of differentiation in HL-60 cells by the reduction of extrachromosomally amplified c-myc. Proc Natl Acad Sci USA 91:6674-6678.
8. Furuya T, Morgan R, Berger C, Sandberg A (1993) Presence of telomeric sequences on deleted chromosomes and their absence on double minutes in cell line HL-60. Cancer Genet Cytogenet 70:132-135.
9. Gallagher R, Collins S, Trujillo J, McCreddie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Ruscetti F, Gallo R (1979) Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54:713-732.
10. Huebner K, Isobe M, Croce CM, Golde DW, Kaufman SE, Gasson JC (1985) The human gene encoding GM-CSF is at 5q21-32, the chromosome region deleted in the 5q- anomaly. Science 230: 1282-1285.
11. Hulsebos T, Schonk D, van Dalen I, Coerwinkel-Driessen M, Schepens J, Ropers HH, Wieringa B (1988) Isolation and characterization of alphoid DNA sequences specific for the pericentric regions of chromosomes 4, 5, 9 and 19. Cytogenet Cell Genet 47:144-148.
12. Joos S, Scherthan H, Speicher MR, Schlegel J, Cremer T, Lichter P (1993) Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe. Hum Genet 90:584-589.
13. Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray J, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
14. Kallioniemi O, Kallioniemi A, Piper J, Isola J, Waldman F, Gray J, Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA copy number changes in solid tumors. Genes Chromosom Cancer 10:231-243.
15. Kamb A, Gruis N, WeaverFeldhaus J, Liu Q, Harshman K, Tavtigian S, Stockert E, Day R, Johnson B, Skolnick M (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
16. Knudson AG (1985) Hereditary cancer, oncogenes and antioncogenes. Cancer Res 45:1437-1443.
17. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD (1986) Clinical and cytogenetic correlations in 63 patients with therapy related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes number 5 and 7. J Clin Oncol 4:325-345.
18. Longo L, Donti E, Mencarelli A, Avanzi G, Pegararo L, Alimena G, Tabilio A, Venti G, Grignani F, Pelicci PG (1990) Mapping of chromosome 17 breakpoints in acute myeloid leukemias. Oncogene 5:1557-1563.
19. Mitelman F (1994) Catalog of Chromosome Aberrations in Cancer, 5th ed. New York: Wiley-Liss.
20. Nagarajan L (1995) Molecular analysis of the 5q- chromosome. Leukemia and Lymphoma 17:361-366.
21. Nagarajan L, Lange B, Cannizzaro L, Finan J, Nowell PC, Huebner K (1990) Molecular anatomy of a 5q interstitial deletion. Blood 75:82-87.
22. Nauseef WM (1986) Myeloperoxidase biosynthesis by a human promyelocytic leukemia cell line: Insight into myeloperoxidase deficiency. Blood 67:865-872.
23. Nobori T, Miura K, Wu D, Lois A, Takabayashi K, Carson D (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756.
24. Nowell PC, Finan J, Dalla-Favera R, Gallo RC, Rushdi A, Romanczuk H, Seldon JR, Emanuel BS, Rovera G, Croce CM (1983) Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukemia cell line. Nature 306:494-497.
25. Otterson GA, Kratzke RA, Coxon A, Kim YW, Kaye FJ (1994) Absence of p16/INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9:3375-3378.
26. Shipley JM, Jones TA, Patel K, Kiely FM, De Stavola BL, Sheer D (1993) Ordering of probes surrounding the Ewing's sarcoma breakpoint on chromosome 22 using fluorescent in situ hybridisation to interphase nuclei. Cytogenet Cell Genet 64:233-239.
27. Wang AM, Creasey AA, Ladner MB, Lin LS, Stickler J, Arsdell JNV, Yamamoto R, Mark DF (1985) Molecular cloning of the complementary DNA for tumor necrosis factor. Science 228:149-154.
28. Waye JS, Willard HF (1986) Structure, organization and sequence of alpha satellite DNA from human chromosome 17: Evidence for evolution by unequal crossing over and an ancestral pentamer repeat shared with the human X chromosome. Mol Cell Biol 6:3156-3165.
29. Wolf D, Rotter V (1985) Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA 82:790-794.
30. Wolman SR, Lanfrancone L, Della-Favera R, Ripley S, Henderson AS (1985) Oncogene mobility in human leukemia. Cancer Genet Cytogenet 17:133-141.